July/August 2017
Biopharma Asia
July/August 2017 | Volume 6 Issue 4
Evolution of Continuous Process in Upstream and its Competition with Fed Batch Platform
Ankur Bhatnagar, Chief Scientific Manager, Cell Culture Lab* Dinesh Baskar, Senior Scien...
Sterile Products Manufacturing- prepared for the future?
Gert Moelgaard, Senior Consultant Moelgaard Consulting, www.moelgaardconsulting.com
Process Analytical Technology for Upstream Bioprocessing
Erica J. Fratz-Berilla, Staff Fellow FDA/CDER/OPQ/OBP/DBRRII Cyrus D. Agarabi, Regulator...
Facilities for Personalised Medicine in the Most Personal Form – Today and Tomorrow writ...
Henriette Schubert, Global Technology Partner NNE A/S
Does BPOG Extractable Protocol truly help? – Case Studies from an End User Perspecti...
Ekta Mahajan, Principal Engineer Genentech/Roche
Changing Column Packing from an Art into a Science
Pall Life Sciences
Is automation the disruption pharma R&D needs?
Barbara Paldus, PhD, Vice President and General Manager, Finesse, a part of Thermo Fisher ...
















